Skip to main content
    I

    ICU Medical Inc (ICUI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $181.87
    +2.60 (+1.45%)

    Market Cap: $4.48B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    ICU Medical Inc (ICUI) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect ICU Medical (ICUI) to earn $8.93 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.19B. Of 8 analysts, 7 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $9.68.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 88% of the ratings.

    RatingAnalystsShare
    Strong Buy337.5%
    Buy450.0%
    Hold112.5%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 8.4% and revenue estimates rise 4.6%.

    Fiscal year ending Dec 31, 2026
    $8.93
    EPS consensus, revenue $2.19B
    Fiscal year ending Dec 31, 2027
    $9.68
    EPS consensus, revenue $2.29B
    Next report
    Feb 17, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$8.93$8.88 to $9.008$2.19B$2.18B to $2.21B8
    Dec 31, 2027$9.68$9.35 to $10.008$2.29B$2.26B to $2.33B8

    Quarterly Estimates

    The EPS consensus falls from $2.21 for the quarter ending Dec 31, 2026 to $2.14 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.21$2.08 to $2.389$570.49M$543.70M to $594.93M9
    Mar 31, 2027$2.14$2.10 to $2.164$545.50M$543.30M to $548.40M3

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 11 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202771
    Quarter ending Mar 31, 202740

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.1% from $8.75.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$8.93$8.75$8.75$8.75$8.75+2.1%
    Fiscal year ending Dec 31, 2027$9.68$9.65$9.65$9.65$9.65+0.3%
    Quarter ending Mar 31, 2027$2.14$2.15$2.15$2.15$2.15-0.6%

    Frequently Asked Questions About ICUI

    What is the ICUI stock forecast?

    Consensus analyst estimates put ICU Medical's EPS at $8.93 for the fiscal year ending Dec 31, 2026, on revenue of $2.19B. The consensus rating from 8 analysts is Buy.

    How do analysts rate ICUI stock?

    Of 8 analysts covering ICU Medical, 3 rate it Strong Buy, 4 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from ICUI next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $8.93, with estimates from $8.88 to $9.00 from 8 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $9.68, with estimates from $9.35 to $10.00 from 8 analysts.

    What revenue do analysts expect from ICU Medical next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.19B, with estimates from $2.18B to $2.21B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.29B, with estimates from $2.26B to $2.33B.

    How many analysts cover ICUI?

    8 analysts rate ICU Medical stock, and 8 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.